You have 9 free searches left this month | for more free features.

malignant gliomas

Showing 26 - 50 of 4,459

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diffuse Intrinsic Pontine Glioma, Malignant Glioma of Brain, High Grade Glioma Trial in United States (ribociclib, Everolimus)

Completed
  • Diffuse Intrinsic Pontine Glioma
  • +6 more
  • Washington, District of Columbia
  • +6 more
Jan 12, 2023

Malignant Glioma, Recurrent Brain Tumor Trial in Rochester (procedure, drug, other)

Active, not recruiting
  • Malignant Glioma
  • Recurrent Brain Neoplasm
  • Biopsy
  • +7 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 5, 2023

Brain and CNS Tumors Trial in Cleveland (aminolevulinic acid, Surgical Resection)

Completed
  • Brain and Central Nervous System Tumors
  • aminolevulinic acid
  • Surgical Resection
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Sep 13, 2021

Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

Withdrawn
  • Recurrent Anaplastic Astrocytoma
  • +7 more
  • Neural Stem Cells-expressing CRAd-S-pk7
  • Resection
  • (no location specified)
Nov 22, 2022

Malignant Glioma Trial in Tampa, Columbus (Hypofractionated Stereotactic Irradiation, Nivolumab, Bevacizumab)

Active, not recruiting
  • Malignant Glioma
  • Hypofractionated Stereotactic Irradiation
  • +3 more
  • Tampa, Florida
  • +1 more
Mar 23, 2022

Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma Trial in San Francisco, Ann Arbor, Zürich (ONC206, Standard of

Recruiting
  • Diffuse Midline Glioma (DMG)
  • +7 more
  • ONC206
  • Standard of Care Radiation Therapy
  • San Francisco, California
  • +2 more
Sep 13, 2022

Low-Grade Gliomas, Malignant Tumors, Brain, Soft Tissue Tumors Trial in United States (MEK162)

Active, not recruiting
  • Low-Grade Gliomas
  • +2 more
  • Birmingham, Alabama
  • +14 more
Jan 25, 2023

Malignant Glioma Trial in Durham (D2C7-IT (6920 ng/mL via convection-enhanced delivery), Atezolizumab (1200 mg every three

Recruiting
  • Malignant Glioma
  • D2C7-IT (6920 ng/mL via convection-enhanced delivery)
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Mar 22, 2022

Immunophenotyping From Blood of Patients With Malignant Gliomas

Active, not recruiting
  • Anaplastic Astrocytoma
  • Glioblastoma Multiforme
  • Blood sample and life quality questionnaires
  • Erlangen, BAY, Germany
    Departement of Radiation Oncology, Universitätsklinikum Erlangen
Apr 26, 2021

Malignant Gliomas, CNS, Brain Cancer Trial in New York (Perifosine)

Completed
  • Malignant Gliomas
  • +3 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Sep 22, 2020

Fluid Therapy, Brain Edema, Brain Tumor Trial in Beijing (SVV-based GDFT, traditional fluid therapy)

Recruiting
  • Fluid Therapy
  • +2 more
  • SVV-based GDFT
  • traditional fluid therapy
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Jan 28, 2022

Brain Cancer Trial in Basking Ridge, Commack, New York (erlotinib, Cytoreductive Surgery)

Completed
  • Brain Cancer
  • Basking Ridge, New Jersey
  • +3 more
Jan 6, 2021

Glioma, Malignant Trial in United States (biological, drug, radiation, other)

Active, not recruiting
  • Glioma, Malignant
  • AdV-tk
  • +5 more
  • Los Angeles, California
  • +7 more
Jan 30, 2023

Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (INCB7839)

Recruiting
  • Glioblastoma Multiforme
  • +5 more
  • Los Angeles, California
  • +12 more
Jan 9, 2023

Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

Active, not recruiting
  • Recurrent Anaplastic Astrocytoma
  • +6 more
  • Carboxylesterase-expressing Allogeneic Neural Stem Cells
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Glial Cell Tumors, Malignant Gliomas, Glioblastoma Multiforme Trial in United States (Valproic acid, Bevacizumab, Radiation

Completed
  • Glial Cell Tumors
  • +7 more
  • Valproic acid
  • +2 more
  • Oklahoma City, Oklahoma
  • +5 more
Jun 30, 2021

Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma Trial in New York (other, drug,

Completed
  • Adult Anaplastic Astrocytoma
  • +8 more
  • Laboratory Biomarker Analysis
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jun 28, 2021

Glioma, Low-grade Glioma, Low Grade Glioma of Brain Trial in Philadelphia (18F-Fluciclovine)

Not yet recruiting
  • Glioma
  • +4 more
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Oct 3, 2022

Glioma, Glioma, Malignant, Glioma, Mixed Trial in United States (NUV-422)

Terminated
  • Glioma
  • +23 more
  • Tucson, Arizona
  • +11 more
Sep 30, 2022

Brain Tumor, Primary, Meningioma, Schwannoma Trial in Seoul

Recruiting
  • Brain Tumor, Primary
  • +4 more
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Feb 14, 2022

    Diffuse Intrinsic Pontine Glioma, Glioma, Malignant Trial in United States (ONC201)

    Recruiting
    • Diffuse Intrinsic Pontine Glioma
    • Glioma, Malignant
    • San Francisco, California
    • +7 more
    Mar 1, 2022

    Malignant Glioma of Brain Trial in New York (5ALA exoscopic fluorescence filter)

    Recruiting
    • Malignant Glioma of Brain
    • 5ALA exoscopic fluorescence filter
    • New York, New York
      Lenox Hill Hospital
    Jun 17, 2021

    Malignant Glioma Trial in Rochester (procedure, drug, radiation, other)

    Active, not recruiting
    • Malignant Glioma
    • Diffusion Weighted Imaging
    • +6 more
    • Rochester, Minnesota
      Mayo Clinic
    Jul 15, 2022

    Malignant Glioma Trial in Boston (Psychological Intervention)

    Completed
    • Malignant Glioma
    • Psychological Intervention
    • Boston, Massachusetts
      Massachusetts General Hospital
    Apr 16, 2020

    Glioma Trial in La Jolla (nilotinib)

    Completed
    • Glioma
    • La Jolla, California
      The Rebecca and John Moores UCSD Cancer Center
    Apr 27, 2020